TOP2A and neoplasm: In addition, similar to our in vitro findings, si-cDCBLD2 treatment in the PDX model resulted in decreased cDCBLD2 (Fig. 8E), increased miR-345-5p (Fig. 8F), and decreased TOP2A mRNA (Fig. 8G) expression levels in the tumor.